Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -0.80% is 142% below its 3-year average of 1.93%, near the low end of its 3-year range (-35.09%–491.55%).
As of the fiscal period ended Tuesday, June 30, 2026. 41.07% below its 12-month average of -0.57%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -0.80%.
RETURN ON EQUITY (ROE)
-0.80%
RETURN ON EQUITY (ROE) AVG TTM
-0.57%
RETURN ON EQUITY (ROE) AVG 3Y
-7.87%
RETURN ON EQUITY (ROE) AVG 5Y
1.93%
RETURN ON EQUITY (ROE) AVG 10Y
-45.20%
RETURN ON EQUITY (ROE) AVG 15Y
-58.85%
RETURN ON EQUITY (ROE) AVG 20Y
-43.47%
CURRENT VS TTM AVG
-41.07%
CURRENT VS 3Y AVG
+89.84%
CURRENT VS 5Y AVG
-141.53%
CURRENT VS 10Y AVG
+98.23%
CURRENT VS 15Y AVG
+98.64%
CURRENT VS 20Y AVG
+98.16%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 753 covered companies
CURRENT VS SECTOR MEDIAN
+98.10%
vs the sector median at left
TherapeuticsMD, Inc.
Market Cap
$23.38M
Return on Equity (ROE)
-0.80%
TTM Avg
-0.57%
3Y Avg
-7.87%
5Y Avg
1.93%
Market Cap
$23.06M
Return on Equity (ROE)
-487.90%
TTM Avg
-205.19%
3Y Avg
-102.69%
5Y Avg
-68.50%
Market Cap
$22.68M
Return on Equity (ROE)
-421.06%
TTM Avg
-298.11%
3Y Avg
-181.82%
5Y Avg
-125.27%
Market Cap
$24.13M
Return on Equity (ROE)
N/A
TTM Avg
-294.82%
3Y Avg
229.70%
5Y Avg
122.55%
Market Cap
$24.44M
Return on Equity (ROE)
-140.55%
TTM Avg
-62.02%
3Y Avg
-44.98%
5Y Avg
-43.41%
Market Cap
$22.25M
Return on Equity (ROE)
-260.37%
TTM Avg
-164.08%
3Y Avg
-188.26%
5Y Avg
-64.22%
Market Cap
$24.60M
Return on Equity (ROE)
-122.19%
TTM Avg
-88.53%
3Y Avg
-83.45%
5Y Avg
-77.50%
Market Cap
$22.00M
Return on Equity (ROE)
-40.40%
TTM Avg
-55.95%
3Y Avg
-53.10%
5Y Avg
-83.38%
Market Cap
$25.22M
Return on Equity (ROE)
-76.82%
TTM Avg
-235.52%
3Y Avg
-335.24%
5Y Avg
-272.42%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | $23.38M | -0.80% | -0.57% | -7.87% | 1.93% |
| Rein Therapeutics Inc. (RNTX)vs › | $23.06M | -487.90% | -205.19% | -102.69% | -68.50% |
| LeonaBio, Inc. (LONA)vs › | $22.68M | -421.06% | -298.11% | -181.82% | -125.27% |
| Kyntra Bio, Inc. (KYNB)vs › | $24.13M | N/A | -294.82% | 229.70% | 122.55% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | -140.55% | -62.02% | -44.98% | -43.41% |
| Modular Medical, Inc. (MODD)vs › | $22.25M | -260.37% | -164.08% | -188.26% | -64.22% |
| InspireMD, Inc. (NSPR)vs › | $24.60M | -122.19% | -88.53% | -83.45% | -77.50% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | -40.40% | -55.95% | -53.10% | -83.38% |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.22M | -76.82% | -235.52% | -335.24% | -272.42% |
| NextCure, Inc. (NXTC)vs › | $20.53M | -351.86% | -122.41% | -86.06% | -64.41% |
ROE
-0.8%
ROA
-0.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -0.80% |
| 2026-03-31 | 0.66% |
| 2025-12-31 | -2.12% |
| 2025-09-30 | 1.10% |
| 2025-06-30 | -1.68% |
| 2025-03-31 | -7.85% |
| 2024-12-31 | -7.97% |
| 2024-09-30 | -12.24% |
| 2024-06-30 | -21.99% |
| 2024-03-31 | -25.85% |
| 2023-12-31 | -35.09% |
| 2023-09-30 | 243.50% |
| 2023-06-30 | 136.94% |
| 2023-03-31 | 491.55% |
| 2022-12-31 | 318.69% |
| 2019-03-31 | -243.39% |
| 2018-12-31 | -135.98% |
| 2018-09-30 | -85.43% |
| 2018-06-30 | -120.85% |
| 2018-03-31 | -74.71% |
| 2017-12-31 | -59.21% |
| 2017-09-30 | -52.40% |
| 2017-06-30 | -94.76% |
| 2017-03-31 | -81.66% |
| 2016-12-31 | -70.50% |
| 2016-09-30 | -57.75% |
| 2016-06-30 | -47.22% |
| 2016-03-31 | -46.41% |
| 2015-12-31 | -134.91% |
| 2015-09-30 | -108.17% |
| 2015-06-30 | -130.55% |
| 2015-03-31 | -75.16% |
| 2014-12-31 | -112.04% |
| 2014-09-30 | -72.79% |
| 2014-06-30 | -96.40% |
| 2014-03-31 | -66.83% |
| 2013-12-31 | -51.99% |
| 2013-09-30 | -41.53% |
| 2013-06-30 | -58.14% |
| 2013-03-31 | -70.62% |
| 2009-09-30 | -351.91% |
| 2008-06-30 | -371.47% |
| 2008-03-31 | 24.20% |
| 2007-12-31 | 40.84% |
| 2007-09-30 | 15.50% |
| 2007-06-30 | 19.68% |
| 2007-03-31 | 21.16% |
| 2006-12-31 | 22.05% |
| 2006-09-30 | 23.85% |
| 2006-06-30 | 23.48% |
| 2006-03-31 | 19.79% |
| 2005-12-31 | 22.06% |
| 2005-09-30 | 22.59% |
| 2005-06-30 | 19.80% |
| 2005-03-31 | 21.59% |
| 2004-12-31 | 13.52% |
| 2004-09-30 | 8.94% |
| 2004-06-30 | 8.10% |
| 2004-03-31 | 6.62% |
| 2003-12-31 | 10.87% |
| 2003-09-30 | 12.23% |
| 2003-06-30 | 10.43% |
